Gu J, Congdon EE, Sigurdsson EM.
Two novel tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce tau pathology.
J Biol Chem. 2013 Nov 15;288(46):33081-95.
Please login to recommend the paper.
Make a Comment
An important study emphasising the validity of a tau-based immunotherapeutic approach in AD.
To make a comment you must login or register.